Deutsche Bank Ag\ Adial Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$36.0 - $42.0 $68,400 - $79,800	-1,900 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	N/A	1,700 Added 850.0%	1,900 $3,000
Q1 2019 May 15, 2019	BUY	N/A	200 New	200 $0

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $27.1M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.